83.855 USD
-3.33 (-3.81%)
ChartMill assigns a Buy % Consensus number of 85% to PTGX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 96.12. This target is 14.62% above the current price.
PTGX was analyzed by 20 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about PTGX.
In the previous month the buy percentage consensus was at a similar level.
PTGX was analyzed by 20 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-12-17 | Barclays | Maintains | Overweight -> Overweight |
| 2025-12-08 | Citigroup | Maintains | Buy -> Buy |
| 2025-11-10 | Citigroup | Maintains | Buy -> Buy |
| 2025-11-07 | Citizens | Maintains | Market Outperform -> Market Outperform |
| 2025-11-07 | Barclays | Maintains | Overweight -> Overweight |
| 2025-11-07 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-10-28 | BTIG | Reiterate | Buy -> Buy |
| 2025-10-28 | Wedbush | Maintains | Outperform -> Outperform |
| 2025-10-28 | Truist Securities | Maintains | Buy -> Buy |
| 2025-10-17 | Citigroup | Maintains | Buy -> Buy |
| 2025-10-08 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-09-17 | Barclays | Initiate | Overweight |
| 2025-09-17 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-09-12 | Leerink Partners | Initiate | Outperform |
| 2025-08-07 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2025-06-17 | Citigroup | Initiate | Buy |
| 2025-06-03 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-05-19 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-04-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-28 | Wedbush | Reiterate | Outperform -> Outperform |
| 2025-03-11 | BMO Capital | Reiterate | Outperform -> Outperform |
| 2025-03-11 | Truist Securities | Maintains | Buy -> Buy |
| 2025-03-11 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-03-10 | Citizens Capital Markets | Reiterate | Market Outperform -> Market Outperform |
| 2025-03-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-04 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-03-03 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-02-24 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2025-02-24 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-02-07 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
PROTAGONIST THERAPEUTICS INC / PTGX FAQ
What do analysts expect the price target to be for PROTAGONIST THERAPEUTICS INC (PTGX)?
20 analysts have analysed PTGX and the average price target is 96.12 USD. This implies a price increase of 14.62% is expected in the next year compared to the current price of 83.855.
What is the consensus rating for PTGX stock?
The consensus rating for PROTAGONIST THERAPEUTICS INC (PTGX) is 85 / 100 . This indicates that analysts generally have a positive outlook on the stock.